Vaccines for Use in Special Populations: Immunocompromised Hosts DOI Creative Commons
Michael G. Ison

The Journal of Infectious Diseases, Год журнала: 2024, Номер unknown

Опубликована: Окт. 15, 2024

Язык: Английский

Does early combination vs. Monotherapy improve clinical outcomes of clinically extremely vulnerable patients with COVID-19? Results from a retrospective propensity-weighted analysis DOI Creative Commons
Maria Mazzitelli, Alberto Enrico Maraolo, Claudia Cozzolino

и другие.

European journal of medical research, Год журнала: 2024, Номер 29(1)

Опубликована: Окт. 4, 2024

Язык: Английский

Процитировано

4
New approach methodologies to assess wanted and unwanted drugs-induced immunostimulation DOI Creative Commons
Valeria Bettinsoli, Gloria Melzi,

I. Marchese

и другие.

Current Research in Toxicology, Год журнала: 2025, Номер 8, С. 100222 - 100222

Опубликована: Янв. 1, 2025

This review examines various classes of drugs, focusing on their therapeutic and adverse effects, particularly in relation to immunostimulation. We emphasize the potential new approach methodologies (NAMs) study both expected unexpected immunostimulatory effects. By evaluating modes action different we aim provide insights into effectively assessing unwanted responses. The begins by exploring drugs that stimulate immune system-including immunostimulants, monoclonal antibodies, chemotherapeutics, nucleic acid-based drugs-to outline NAMs could be employed evaluate

Язык: Английский

Процитировано

0
COVID-19 convalescent plasma in immunocompromised COVID-19 patients: more certainty and clarity are added to a complex evidence base DOI
Hyunah Yoon, Liise-anne Pirofski

EBioMedicine, Год журнала: 2025, Номер 114, С. 105654 - 105654

Опубликована: Март 18, 2025

Язык: Английский

Процитировано

0
Interferon-α Nasal Spray to Prevent COVID-19 and Respiratory Viral Infections in Cancer Patients; a Randomised, Double-Blinded Placebo-Controlled Trial DOI
Michelle K. Yong, Karin Thursky, Megan Crane

и другие.

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

0
Fresh frozen plasma for neutralizing SARS-CoV-2: “An exploratory cross-sectional study and review of the state of the art” DOI

Marcial Delgado‐Fernández,

Juan Diego Ruíz-Mesa,

Almudena Rojas-González

и другие.

Enfermedades Infecciosas y Microbiología Clínica, Год журнала: 2025, Номер unknown

Опубликована: Апрель 1, 2025

Язык: Английский

Процитировано

0
Author Response to: “COVID-19 Outcomes Among Hematopoietic Cell Transplant and Chimeric Antigen Receptor T-cell Recipients: Correspondence” DOI

Emily A. Rosen,

Catherine Liu

Transplantation and Cellular Therapy, Год журнала: 2024, Номер unknown

Опубликована: Сен. 1, 2024

Язык: Английский

Процитировано

2
Bridging the Gap: Delphi Consensus Statements for SARS-CoV-2 Vaccination in Immunocompromised Patients DOI Creative Commons
Hersh D. Ravkin, Lior Nesher

Infectious Diseases and Therapy, Год журнала: 2024, Номер 13(11), С. 2223 - 2225

Опубликована: Окт. 10, 2024

Язык: Английский

Процитировано

0
Vaccines for Use in Special Populations: Immunocompromised Hosts DOI Creative Commons
Michael G. Ison

The Journal of Infectious Diseases, Год журнала: 2024, Номер unknown

Опубликована: Окт. 15, 2024

Язык: Английский

Процитировано

0